Diabetes Information

  • Diabetes Educators Slider

    We believe: The greatest solutions arise from collaboration.

    Evidence + Judgment = Best Care

    Start Here

Latest Updates

Health Canada temporarily authorized the adjunctive use of the Dexcom G6 Continuous Glucose Monitoring (CGM) system during COVID-19 by pregnant women with Type 1, Type 2, or gestational diabetes to compliment the use of blood glucose meters until March 18, 2021, unless the authorization requires changes within that timeframe.  For more information, please review the formal update on the Health Canada Website.

Diabetes Update Sign-Up

Stay up-to-date with diabetes education and management. Receive updates on new medications, products, continuing education for healthcare professionals and more by signing up for our periodic emails.

To view past updates, please visit our archives.